Human rhinovirus induces robust IP‐10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation

Human rhinovirus (HRV)‐induced respiratory infections are associated with elevated levels of IFN‐γ‐inducible protein 10 (IP‐10), which is an enhancer of T lymphocyte chemotaxis and correlates with symptom severity and T lymphocyte number. Increased IP‐10 expression is exhibited by airway epithelial cells following ex vivo HRV challenge and requires intracellular viral replication; however, there are conflicting reports regarding the necessity of type I IFN receptor ligation for IP‐10 expression. Furthermore, the involvement of resident airway immune cells, predominantly bronchoalveolar macrophages, in contributing to HRV‐stimulated IP‐10 elaboration remains unclear. In this regard, our findings demonstrate that ex vivo exposure of human peripheral blood monocytes and bronchoalveolar macrophages (monocytic cells) to native or replication‐defective HRV serotype 16 (HRV16) resulted in similarly robust levels of IP‐10 release, which occurred in a time‐ and dose‐dependent manner. Furthermore, HRV16 induced a significant increase in type I IFN (IFN‐α) release and STAT1 phosphorylation in monocytes. Neutralization of the type I IFN receptor and inhibition of JAK or p38 kinase activity strongly attenuated HRV16‐stimulated STAT1 phosphorylation and IP‐10 release. Thus, this work supports a model, wherein HRV16‐induced IP‐10 release by monocytic cells is modulated via autocrine/paracrine action of type I IFNs and subsequent JAK/STAT pathway activity. Our findings demonstrating robust activation of monocytic cells in response to native and/or replication‐defective HRV16 challenge represent the first evidence indicating a mechanistic disparity in the activation of macrophages when compared with epithelial cells and suggest that macrophages likely contribute to cytokine elaboration following HRV challenge in vivo.

[1]  H. Boushey,et al.  Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. , 2006, American journal of respiratory cell and molecular biology.

[2]  D. Proud,et al.  Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[3]  W. Busse,et al.  Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. , 2004, American journal of respiratory and critical care medicine.

[4]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[5]  Lin Ying Liu,et al.  Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge. , 2003, The Journal of allergy and clinical immunology.

[6]  Wai-ming Lee,et al.  Human Rhinovirus Type 16: Mutant V1210A Requires Capsid-Binding Drug for Assembly of Pentamers To Form Virions during Morphogenesis , 2003, Journal of Virology.

[7]  Kunling Shen,et al.  Relationships among specific viral pathogens, virus‐induced interleukin‐8, and respiratory symptoms in infancy , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[8]  B. Medoff,et al.  IFN-γ-Inducible Protein 10 (CXCL10) Contributes to Airway Hyperreactivity and Airway Inflammation in a Mouse Model of Asthma1 , 2002, The Journal of Immunology.

[9]  W. Busse,et al.  Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. , 2002, The Journal of infectious diseases.

[10]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[11]  M. Yacoub,et al.  Effects of cross-linking ICAM-1 on the surface of human vascular smooth muscle cells: induction of VCAM-1 but no proliferation. , 2001, Cardiovascular research.

[12]  W. Busse,et al.  The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. , 2000, The Journal of allergy and clinical immunology.

[13]  P. Dragovich,et al.  Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor , 2000, Antimicrobial Agents and Chemotherapy.

[14]  S. Romagnani The role of lymphocytes in allergic disease. , 2000, The Journal of allergy and clinical immunology.

[15]  W. Busse,et al.  Association of Rhinovirus Infections with Asthma , 1999, Clinical Microbiology Reviews.

[16]  R. Turner,et al.  Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Wai-ming Lee,et al.  WIN 52035-Dependent Human Rhinovirus 16: Assembly Deficiency Caused by Mutations near the Canyon Surface , 1998, Journal of Virology.

[18]  M. Yamaya,et al.  Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[19]  W. Busse,et al.  Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. , 1997, American journal of respiratory and critical care medicine.

[20]  W. Busse,et al.  Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. , 1996, Journal of immunology.

[21]  W. Busse,et al.  Rhinovirus enters but does not replicate inside monocytes and airway macrophages. , 1996, Journal of immunology.

[22]  S. Johnston Natural and experimental rhinovirus infections of the lower respiratory tract. , 1995, American journal of respiratory and critical care medicine.

[23]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.

[24]  D. Taub,et al.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.

[25]  R. Rueckert,et al.  WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14 , 1993, Journal of virology.

[26]  J. Greve,et al.  Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion , 1993, Journal of virology.

[27]  S. Johnston,et al.  Viruses as precipitants of asthma symptoms. I. Epidemiology , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[29]  G. Jackson,et al.  Nasal‐Secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection , 1988, Journal of medical virology.

[30]  P. Suratt,et al.  Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. , 1983, The American review of respiratory disease.

[31]  J. N. Wilson,et al.  THE EFFECT OF LIGHT ON POLIOVIRUS GROWN IN NEUTRAL RED. , 1965, Virology.